Skip to main content
. 2022 Dec 1;53(3):668–686. doi: 10.1017/S0033291722003634

Table 1.

Number of studies and sample sizes by treatment and study characteristics

# studies N # studies N # studies N
Settinga Outpatient Day-treatment Inpatient
83 4938 15 1158 17 3004
Formata Individual + Group Individual Group
74 6595 43 1652 13 853
Study design Open Trial RCT Non-randomized controlled
58 5008 44 3397 9 695
Add-on to TAUa Not added to TAU Added to TAU
110 8853 7 247
Medication Not prescribed Prescribed
106 8946 5 154
Dropout type Treatment dropout distinguished from Study dropout Study and treatment dropout not distinguished
90 7775 21 1325
Dropout per Quarterb Completely reported Partially reported Not reported
87 7232 7 483 20 1385
Country group Europe USA Australia/Canada/NewZealand Emerging
48 4781 27 1089 6 418 418 341
a

Note that some studies investigated multiple settings/formats/models. Hence, #studies >111 in these rows.

b

Note that some studies had complete dropout reports for one arm, but not or partially reported for another arm. Hence, #studies >111 in this row.